AzTrials
AzTrials

Postmenopausal WomenNCT05324956

The Relationship Between Bone Mineral Density With Respiratory Functions and Exercise Capacity

An observational study of Postmenopausal Women, run by Izmir Bakircay University at 1 site in Turkey (Türkiye).

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

If the bone mineral density of a patient with a diagnosis of osteopenia falls further, he develops osteoporosis.Menopause causes many changes in women's bodies in the form of vasomotor, sleep disorders, fatigue, aches and pains, altered cognitive functions, as well as genitourinary problems such as vaginal dryness… Read more about this study

Who is it for?
Ages 40 to 80 years, women onlyHealthy volunteers can take part
Conditions the study is for
Postmenopausal Women
How many people
80 participants
Where
1 siteTurkey (Türkiye)
Study dates
Apr 2022to Jun 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 80 years
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Postmenopausal women aged between 40-80 years old and diagnosed with osteoporosis or osteopenia

Who may be able to join

  • Between 40-80 years old
  • Female gender
  • Being diagnosed with menopause
  • Being diagnosed with osteoporosis or osteopenia
  • Volunteer to participate in the study

Who cannot join

  • Hemoptysis of unknown cause
  • Recent abdominal, thoracic, or eye surgery
  • Thoracic, abdominal, or cerebral aneurysm
  • pulmonary embolism
  • Mental state disorder that interferes with cooperation
  • Arrhythmias disrupting hemodynamics
Show all 13Show fewer
  • Having any diagnosed disease affecting the respiratory system
  • pneumothorax
  • unstable angina
  • Recent myocardial infarction
  • Thrombosis in lower extremity
  • Acute myocarditis
  • Other diseases that will prevent exercise (infection, kidney failure)

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Öykünur CANSU

    Izmir

Other trials in Turkey (Türkiye)

About this study

Official title: The Relationship Between Bone Mineral Density With Respiratory Functions and Exercise Capacity in Postmenopausal Women

If the bone mineral density of a patient with a diagnosis of osteopenia falls further, he develops osteoporosis.Menopause causes many changes in women's bodies in the form of vasomotor, sleep disorders, fatigue, aches and pains, altered cognitive functions, as well as genitourinary problems such as vaginal dryness, irritation, recurrent urinary tract infections. In the long term, inevitable changes occur in the musculoskeletal system. Osteoporosis, sarcopenia, postural dysfunction, regression in gait cycle, Loss of balance control and instability and increased risk of falling are the changes reported during this period. These mentioned effects negatively affect the quality of life of women. The aim of this study is to investigate the relationship of bone mineral density with respiratory functions and exercise capacity in postmenopausal women.The second aim is to compare the respiratory functions and exercise capacities of postmenopausal women with osteopenia and osteoporosis.

Read the detailed description

The 1993 Consensus Development Conference paper defined osteoporosis as ''a disease characterized by low bone mass and microarchitectural deterioration of bone tissue, leading to increased bone fragility and consequent increased risk of fracture.In 1994, the World Health Organization (WHO) established criteria for measuring bone mineral density (BMD) that allowed the diagnosis of osteoporosis before fractures. This practical definition is based on the main (known) risk factor: reduced bone strength or density and people at high risk but without fractures.Premenopausal women have a low rate of osteoporosis; however, the prevalence increases with age due to progressive bone loss.Bone densitometry is an established method for evaluating osteoporosis. Various different methods have been developed in the last 25 years. DEXA is recommended and FDA approved for BMD measurement; It is precise, noninvasive, has low radiation exposure and takes 10 minutes to administer. Osteoporosis can have a significant impact on patients' daily lives. Vertebral deformity causes loss of spinal mobility, and patients with osteoporosis have difficulty standing, bending over, getting up from a chair, walking, carrying objects, dressing, fixing hair, bathing, moving in bed, using the toilet, and descending to the floor. Compared with women without existing vertebral deformities, women with extensive deformities have higher crude mortality and hospitalization rates overall.Osteoporosis deprives older women of many of their social roles. Failure to fulfill roles such as cooking, housework, work, and intimacy can be devastating, leading to frustration and embarrassment. Interpersonal relationships can be deeply affected by the effects of osteoporosis, straining family ties and destroying extra-familial relationships, leading to social isolation. Therefore, treatment options should be well evaluated because affected individuals should focus not only on bone remodeling, but also on ways in which negative outcomes such as pain, depression and loss of self-esteem can be improved. Considering all these situations, we asked the question whether there is any relationship between bone mineral density and respiratory functions and exercise capacity. In order to evaluate these parameters, we decided to examine the patient's detailed demographic information, posture evaluation according to the New York Posture Scale, 6-minute walking test result, and Pulmonary Function Test result.

Being tested
No intervention
Keywords
Osteopenia, Osteoporosis, Spirometry, 6 Minute Walk Test, New York Posture Rating Chart
Medical subject headings
Bone Diseases, Metabolic, Osteoporosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • No interventionOther

    Individuals will not receive any interventions

Study groups in NCT05324956
Study groupRoleWhat they receive
Postmenopausal WomenPostmenopausal women be between 40-79 years and being diagnosed with osteoporosis or osteopenia
Receives: Other: No intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Evaluation of Respiratory Functions

    Spirometry will be applied to evaluate respiratory functions.It is the most commonly performed lung function test, which evaluates volume against time using a device called a spirometer. The expiratory time should be at least 6 seconds and extended up to 15 seconds if necessary.The patient is instructed to take a deep breath and blow as hard and as fast as possible and take a deep breath to complete the flow volume cycle. The one with the highest values out of at least three tests done in succession is selected.

    Measured: at baseline

  2. Evaluation of Exercise Capacity

    6 Minutes Walking Test will be applied to evaluate exercise capacity. The goal of this test is to walk the maximum distance that can be walked in 6 minutes. Average walking distances: 20/50 age:590-640m 60/70 age:540/570m 70/80 age:470-530m.

    Measured: at baseline

  3. Posture Assessment

    Posture assessment will be made using the New York Posture Rating Chart (NYPR).NYPR is an inexpensive, easy and fast-applied subjective postural assessment method that is widely used for clinical postural assessment. The grading chart is used to evaluate 13 areas of the body based on the assumption that posture is the alignment of the body and its parts.Each field is awarded a point based on position: 5 points for correct position; 3 points for a slight deviation and 1 point for a significant deviation. The total score ranges from 18-90 points. The higher the score, the better the postural alignment.

    Measured: at baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Apr 2022
  2. Study startApr 2022 (estimated)
  3. Primary completionApr 2022 (estimated)
  4. Study completionJun 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05324956
Sponsor's protocol ID
2021/348
Status last verified
Apr 2022
First submitted
22 Feb 2022
Last updated
13 Apr 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Postmenopausal Women, run by Izmir Bakircay University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 13 Apr 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Öykünur Cansu (+902324930000, 6009121@bakircay.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Evaluation of Respiratory Functions (time frame: at baseline). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Apr 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in